GleamWall
中文EN

EYPT EyePoint, Inc.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1314102 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-93.9%
TTM net income YoY-66.5%
TTM EPS YoY-32.3%
Revenue 3-yr CAGR-60.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-13,642.0%
Net margin-13,281.2%
FCF margin-11,599.4%
EBITDA margin-13,533.9%

Returns

ROE-221.9%
ROA-164.0%
ROIC (approx.)-368.4%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets34.7%
Debt / equity0.00x
Current ratio3.30x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.86x
Accruals ratio-22.9%
Payout ratio—
Capex / revenue170.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$756,000$507,000$696,000$620,000$966,000$5.33M$24.45M$11.59M
R&D expense$81.67M$83.61M$72.15M$59.21M$47.75M$55.50M$58.57M$43.37M
SG&A expense$15.41M$14.24M$15.24M$11.38M$14.49M$11.86M$13.88M$12.59M
Operating income-$96.88M-$97.38M-$87.23M-$70.34M-$62.02M-$62.23M-$48.84M-$45.24M
Pretax income-$95.61M-$94.47M—-$67.42M-$59.73M-$59.33M—-$41.31M
Income tax$0$0-$50,000$186,000$0$93,000$0$90,000
Net income-$95.61M-$94.47M-$84.83M-$67.61M-$59.73M-$59.43M-$45.20M-$41.40M
EBITDA-$96.11M-$96.69M-$86.59M-$69.65M-$61.45M-$61.69M-$48.34M-$44.77M
EPS (basic)-1.07-1.09-0.99—-0.85-0.85-0.65—
EPS (diluted)-1.07-1.09-0.99—-0.85-0.85-0.65—
Weighted avg. shares (diluted)89,24586,54385,999—70,16869,92669,767—
Balance sheet
Cash & equivalents$83.21M$110.46M$77.71M$101.82M$74.58M$71.14M$85.16M$99.85M
Short-term investments$35.01M$70.01M$144.83M$204.26M$129.44M$184.59M$233.04M$271.21M
Inventory$1.67M$1.88M$1.25M$1.81M$2.11M$2.68M$2.13M$2.31M
Current assets$126.99M$188.82M$249.50M$328.65M$216.11M$265.25M$326.98M$383.31M
PP&E, net$10.30M$10.01M$9.48M$9.02M$8.86M$8.76M$8.04M$8.18M
Total assets$166.14M$228.19M$288.22M$364.00M$251.69M$301.15M$362.56M$418.46M
Current liabilities$38.51M$41.94M$37.46M$37.02M$30.09M$33.17M$41.68M$49.05M
Total liabilities$57.63M$61.78M$57.74M$57.88M$51.51M$55.14M$64.17M$81.96M
Shareholders' equity$108.51M$166.41M$230.47M$306.11M$200.18M$246.01M$298.40M$336.50M
Shares outstanding90.77M84.98M83.45M82.83M69.57M68.89M68.81M68.27M
Cash flow statement
Operating cash flow-$86.82M-$62.35M-$80.55M-$65.05M-$59.35M-$62.59M-$53.12M-$35.85M
Capital expenditure$1.21M$1.20M$997,000$986,000$798,000$1.22M$276,000$384,000
Free cash flow-$88.02M-$63.55M-$81.55M-$66.03M-$60.15M-$63.81M-$53.40M-$36.23M
Investing cash flow$33.79M$75.10M$59.05M-$74.67M$55.38M$48.34M$39.52M-$95.96M
Financing cash flow$25.77M$19.99M-$2.61M$166.96M$7.40M$238,000-$951,000$151.69M
Depreciation & amortization$765,000$690,000$636,000$698,000$576,000$538,000$497,000$467,000
Stock-based compensation$11.87M$10.40M$11.64M$6.75M$6.43M$6.88M$7.82M$7.90M

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.